Journal of Neuro-Oncology

, Volume 26, Issue 1, pp 1–9

Nuclear morphometry and DNA densitometry of human gliomas by image analysis

  • Yoshihiko Yoshii
  • Atsushi Saito
  • Tadao Nose
Laboratory Investigation


In 48 patients with gliomas in whom complete clinical follow-up was obtained, DNA ploidy was evaluated by using formalin-fixed paraffin-embedded tissues and by means of image analysis. The mean DNA indices, determined by averaging DNA indices of all tumor cells in a tumor, were mainly affected by mean DNA indices of the nuclei of SG2M phase tumor cell (including S phase and G2M phase cells) (SG2M DNA indices) and that mean DNA indices correlated with the SG2M phase fraction. The SG2M DNA indices and the percentage of tumor cells with S phase and G2M phase were higher in high grade gliomas including anaplastic glioma and glioblastoma multiforme than in low grade gliomas. Patients with G2M-hypertetraploid tumors demonstrated a shorter time to tumor progression than those with G2M-tetraploid in high grade glioma. Morphometrically, the nuclei of SG2M phase glioma cells were larger and more deformity than those of G0G1 phase (including G0 phase and G1 phase cells) cells. The G2M-hypertetraploid tumors were highly malignant and demonstrated large nuclei, greater nuclear deformity, and a higher proliferative potential. The G2M-tetraploid gliomas demonstrated a shorter time to tumor progression in cases whose the SG2M fraction was large. In contrast, G2M-hypotetraploid gliomas revealed an insignificant trend towards a longer time to tumor progression than those associated with tetraploid and hypertetraploid gliomas. We emphasize herein the prognostic importance of the SG2M phase cell, as well as other proliferation indices.

Key words

human gliomas DNA index G2M phase cell image cytometry morphometry 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bigner SH, Bjerkvig R, Laerum OD: DNA content and chromosomal composition of malignant human gliomas. Neurology Clinics 3: 769–783, 1985Google Scholar
  2. 2.
    Christov K, Zapryanov Z: Flow cytometry in brain tumors. I. ploidy abnormalities. Neoplasma 33: 49–55, 1986PubMedGoogle Scholar
  3. 3.
    Hoshino T, Nomura K, Wilson CB, Knebel KD, Gray JW: The distribution of nuclear DNA from human brain-tumor cells: Flow cytometric studies. J Neurosurg 49: 13–21, 1978PubMedGoogle Scholar
  4. 4.
    Kawamoto K, Herz F, Wolley RC, Hirano A, Koss LG: Flow cytometric analysis of the DNA content in cultured human brain tumor cells. Virchows Arch (Cell Pathol) 35: 11–17, 1980Google Scholar
  5. 5.
    Kawamoto K, Sakai N, Numa Y, Imahori T, Matsumura H: Significance of flow cytometric measurement of DNA-index in gliomas. Brain Tumor Pathol 8: 177–181, 1991Google Scholar
  6. 6.
    Giangaspero F, Chieco P, Lisignoli G, Burger PC: Comparison of cytologic composition with microfluormetric DNA analysis of the glioblastoma multiforme and anaplastic astrocytoma. Cancer 60: 59–65, 1987PubMedGoogle Scholar
  7. 7.
    Kawamoto K, Herz F, Wolley RC, Hirano A, Kajikawa H, Koss LG: Flow cytometric analysis of DNA distribution in human brain tumors. Acta Neuropathol (Berl) 46: 39–44, 1979Google Scholar
  8. 8.
    Lehmann J, Krug H: Flow-through fluorocytophotometry of different brain tumors. Acta Neuropathol (Berl) 49: 123–132, 1980Google Scholar
  9. 9.
    Mork SJ, Laerum OD: Modal DNA content of human intracranial neoplasms studied by flow cytometry. J Neurosurg 53: 198–204, 1980PubMedGoogle Scholar
  10. 10.
    Salmon I, Kiss R, Dewitte O, Gras T, Pasteels JL, Brotchi J, Flament-Durand J: Histopathologic granding and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients. Cancer 70: 538–546, 1992PubMedGoogle Scholar
  11. 11.
    Salmon I, Levivier M, Camby I, Rombaut K, Gras T, Pasteels JL, Brotchi J, Kiss R: Assessment of nuclear size, nuclear DNA content and proliferation index in stereotaxic biopsies from brain tumors. Neuropathology and Applied Neurobiology 19: 507–518, 1993PubMedGoogle Scholar
  12. 12.
    Spaar FW, Ahyai A, Blech M: DNA-fluorescence cytometry and prognosis (grading) of meningiomas. A study of 104 surgically removed tumors. Neurosurg Rev 10: 35–39, 1987PubMedGoogle Scholar
  13. 13.
    Kute TE, Muss HB, Hopkins M, Marshall R, Case D, Kammire L: Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer. Breast Cancer Res Treat 6: 113–121, 1985PubMedGoogle Scholar
  14. 14.
    Auer G, Caspersson TO, Wallgren AS: DNA content and survival in mammary carcinoma. Anal Quant Cytol 2: 161–165, 1980PubMedGoogle Scholar
  15. 15.
    Banner BF, Branczio L, Bahnson RR, Ernstoff MS, Taylor SR: DNA analysis of multiple synchronous renal cell carcinomas. Cancer 66: 2180–2185, 1990PubMedGoogle Scholar
  16. 16.
    Becker RL, Mikel UV: Interrelation of formalin fixation, chromatin compactness and DNA values as measured by flow and image cytometry. Analytical and Quantitative Cytology and Histology 12: 333–341, 1990PubMedGoogle Scholar
  17. 17.
    Cope C, Rowe D, Delbridge L, Philips J, Friedlander M: Comparison of image analysis and flow cytometric determination of cellular DNA content. J Clin Pathol 44: 147–151, 1991PubMedGoogle Scholar
  18. 18.
    Davenport RD, Mckeever PE: Ploidy of endothelium in high-grade astrocytomas. Analytical and Quantitative Cytology and Histology 9: 25–29, 1987PubMedGoogle Scholar
  19. 19.
    Greene DR, Taylor SR, Wheeler TM, Scardino PT: DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report: Cancer Res 51: 4084–4089, 1991PubMedGoogle Scholar
  20. 20.
    Martin H, Voss K: Automated image analysis of glioblastomas and other gliomas. Acta Neuropathol (Berl) 58: 9–16, 1982Google Scholar
  21. 21.
    Martin H, Voss K: Computerized classification of gliomas by automated microscope pictur analysis (AMPA). Acta Neuropathol (Berl) 58: 261–268, 1982Google Scholar
  22. 22.
    Martin H, Vos K, Hufnagl P, Frolich K: Automated image analysis of gliomas an objective and reproducible method for tumor granding. Acta Neuropathol (Berl) 63: 160–169, 1984Google Scholar
  23. 23.
    Mikel UV, Becker RL: A comparative study of quantitative stains for DNA in image cytometry. Analytical and Quantitative Cytology and Histology 13: 253–259, 1991PubMedGoogle Scholar
  24. 24.
    Mikel UV, Fishbein WN, Bahr GF: Some practical considerations in quantitative absorbance microspectro-photometry: Preparation techniques in DNA cytophotometry. Analytical and Quantitative Cytology and Histology 7: 107–118, 1985PubMedGoogle Scholar
  25. 25.
    Saito A, Yoshii Y, Nose T: Image analysis of nuclear DNA content and morphometrical characteristics of the tumor cells in human astrocytomas. Brain Tumor Pathoi 11: 143–146, 1994Google Scholar
  26. 26.
    Salmon I, Kiss R, Levivier M, Remmelink M, Pasteels JL, Brotchi J, Flament-Durant J: Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors. Am J Surg Pathol 17: 239–247, 1993PubMedGoogle Scholar
  27. 27.
    Schad LR, Schmitt HP, Oberwittler C, Lorenz WJ: Numerical granding of astrocytoma. MED INFORM 12: 11–22, 1987Google Scholar
  28. 28.
    Stockle M, Storkel S, Mielke R, Steinbach F, El-Damanhoury H, Voges G, Hohenfellner R: Characterization of conservatively resected renal tumors using automated image analysis DNA cytometry. Cancer 68: 1926–1931, 1991PubMedGoogle Scholar
  29. 29.
    Ullen H, Falkmer UG, Collins VP, Auer GU: Methodologic aspects of nuclear DNA assessment of gliomas with astrocytic and/or oligodendrocytic differentiation. Correlation of image and flow cytometric studies on paraffin-embedded specimens. Analytical and Quantitative Cytology and Histology 13: 168–176, 1991PubMedGoogle Scholar
  30. 30.
    Yoshii Y, Saito A, Tsuboi K, Tsurushima H, Komatsu Y, Tomono Y, Nose T: Nuclear characterization and G2M ploidy in human brain tumors using semiautomated image analysis. Brain Tumor Pathol 12: 61–67, 1995Google Scholar
  31. 31.
    Zaprianov Z, Christov K: Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors. Cytometry 9: 380–386, 1988PubMedGoogle Scholar
  32. 32.
    Dressler LG: Controls, standards, and histogram interpretation in DNA flow cytometry. In: Darzynkiewicz Z, Crissman HA (eds) Flow Cytometry: Methods in Cell Biology Vol 33, Academic Press, Inc. San Diego, 1990, pp 157–171Google Scholar
  33. 33.
    Ahyai A, Spaar FW: DNA and prognosis of meningiomas: a comparative cytological and fluorescence-cytophotometrical study of 71 tumors. Acta Neurochirurgica 87: 119–128, 1987PubMedGoogle Scholar
  34. 34.
    Appley AJ, Fitzgibbons PL, Chandrasoma PT, Hinton DR, Apuzzo M: Multiparameter flow cytometric analysis of neoplasms of the central nervous system: Correlation of nuclear antigen p105 and DNA content with clinical behavior. Neurosurgery 27: 83–96, 1990PubMedGoogle Scholar
  35. 35.
    Broggi G, Franzini A, Costa A, Melcarne A, Allegranza A: Cell kinetics of neuroepithelial tumors in serial stereotactic biopsies. A new combined approach. Appl Neurophysiol 48: 472–476, 1985PubMedGoogle Scholar
  36. 36.
    Coos SW, Davis JR, Way DL: Correlation of DNA content and histology in prognosis of astrocytomas. Am J Clin Pathol 90: 289–293, 1988PubMedGoogle Scholar
  37. 37.
    Danova M, Giaretti W, Merlo F, Mazzini G, Gaetani P, Geido E, Gentile S, Butti G, Vincini AD, Riccardi A: Prognostic significance of nuclear DNA content in human neuroepithelial tumors. Int J Cancer 48: 663–667, 1991PubMedGoogle Scholar
  38. 38.
    DeReuck J, Sieben G, DeCoster W, Roels H, Vander Eecken H: Cytophotometric DNA determination in human oligodendroglial tumors. Histopathology 4: 225–232, 1980PubMedGoogle Scholar
  39. 39.
    Fitzgibbons PL, Turner RR, Appley AJ, Bishop PL, Nichols P, Epstein AL, Apuzzo ML, Chandrasoma PT: Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms. Am J Clin Pathol 89: 640–644, 1988PubMedGoogle Scholar
  40. 40.
    Hoshino T, Wilson CB, Eillis WG: Gemistocytic astrocytes in gliomas: An autoradiographic study. J Neuropathol Exp Neurol 34: 263–281, 1975PubMedGoogle Scholar
  41. 41.
    Ironside JW, Battersby RDE, Lawry J, Loomes RS, Day CA, Timperley WR: DNA in meningioma tissues and explant cell cultures, a flow cytometric study with clinicopathology correlates. J Neurosurg 66: 588–594, 1987PubMedGoogle Scholar
  42. 42.
    May PL, Broome JC, Lawry J, Buxtoh RA, Battersoy RD: The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material. J Neurosurg 71: 347–351, 1989PubMedGoogle Scholar
  43. 43.
    Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K: Flow cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdr labeling indices in human brain tumors. J Neurosurg 70: 379–384, 1989PubMedGoogle Scholar
  44. 44.
    Vindelov LL, Christensen IJ, Jensen G, Nissen NI: Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Cytometry 3: 332–339, 1983PubMedGoogle Scholar
  45. 45.
    Laerum OD, Farsund T: Clinical applications of flow cytometry. Cytometry 2: 1–13, 1981PubMedGoogle Scholar
  46. 46.
    Shapiro WR, Shapiro JR: Principles of brain tumor chemotherapy. Semin Oncol 13: 56–69, 1986PubMedGoogle Scholar
  47. 47.
    Frederiksen P, Raske-Nelson E, Bichel P: Flow cytometry in tumors of the brain. Acta Neuropathol (Berl) 41: 179–183, 1978Google Scholar
  48. 48.
    Hoshino T, Wilson CB: Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 44: 956–962, 1979PubMedGoogle Scholar
  49. 49.
    Hoshino T, Townsend JJ, Muradea I, Wilson CB: An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme. Brain 103: 967–984, 1980PubMedGoogle Scholar
  50. 50.
    Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MS, Gutin PH, Davis RL, DeArmond S:In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 64: 453–459, 1986PubMedGoogle Scholar
  51. 51.
    Nagashima T, DeArmond SJ, Murovic J, Hoshino T: Immunocytochemical demonstration of S-phase cells by antibromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67: 155–159, 1985Google Scholar
  52. 52.
    Yoshii Y, Maki Y, Tsuboi K, Tomono Y, Nakagawa K, Hoshino T: Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors. J Neurosurg 65: 659–693, 1986PubMedGoogle Scholar
  53. 53.
    Yoshii Y, Narushiama K, Tsuboi K, Maki Y, Sugiyama K: Tumor cord and growth in human brain tumors based on mathematical morphology. J Neuro Oncol 6: 119–128, 1988Google Scholar
  54. 54.
    Yoshii Y, Sugiyama K: Intercapillary distance in the proliferating area of human glioma. Cancer Res 48: 2938–2941, 1988PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Yoshihiko Yoshii
    • 1
  • Atsushi Saito
    • 1
  • Tadao Nose
    • 1
  1. 1.Dept. of Neurological SurgeryUniversity of TsukubaIbarakiJapan

Personalised recommendations